Court restricts abortion access across US by blocking mailing of mifepristone
abcnews - A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone
AI Summary: A federal appeals court has imposed new limits on distribution of mifepristone, blocking mail-order shipments and narrowing telehealth-based prescribing. The decision immediately complicates access for patients and clinicians who rely on remote care and pharmacy delivery, forcing last‑minute logistical changes, increased travel, and swift legal and policy responses as providers scramble to adapt.
- Appeals court halts mail and telehealth access (4)
- Clinical pivots and drug alternatives amid disruptions (3)
- Supreme Court temporarily restores mail access (5)
- All Other Stories
Appeals court halts mail and telehealth access
Clinical pivots and drug alternatives amid disruptions
Supreme Court temporarily restores mail access
All Other Stories
U.S. Government Will Stop Paying for Test Strips to Detect Deadly Drugs
Jan Hoffman / nytimes - In a letter to states and other grant recipients, the Trump administration says the strips encourage drug use.
AI Summary: Public health officials have declared the South Carolina measles outbreak over after nearly 1,000 people fell ill, attributing containment to intensified vaccination campaigns and contact tracing. Authorities warn that immunity gaps still exist and stressed that preventable outbreaks will recur without sustained immunization efforts — a blunt reminder that vaccines remain the easiest way to avoid headline-making contagions.
Cigna exits ACA exchanges despite dramatic profit growth in Q1
Rebecca Pifer Parduhn / healthcaredive - The insurer plans to say goodbye to the ACA exchanges after this year, and is exploring a potential sale of its controversial claims review subsidiary. Both businesses were more trouble than they were worth, executives said.
AI Summary: Cigna announced it will withdraw from Affordable Care Act individual exchanges even after reporting robust first-quarter earnings. The insurer cites strategic and operational reasons for exiting markets where risk and costs bite, a move likely to reduce competition in some states and could leave consumers with fewer plan choices or higher premiums.
WHO approves first malaria treatment for infants
medicalxpress - The World Health Organization announced Friday that it had given prequalification approval to a malaria treatment for newborns and infants for the first time.
AI Summary: The World Health Organization has cleared the first malaria treatment specifically for infants, granting prequalification that paves the way for broader procurement and use in endemic countries. Regulators' sign-off targets a vulnerable age group long underserved by effective pediatric therapies, potentially speeding distribution through global health channels and donor programs.
Distribution of Phase I lung cancer trials may be consolidating at top-performing US sites
medicalxpress - Between 2020 and 2024, the number of unique sites in the United States where phase I clinical trials for non-small cell lung cancer (NSCLC) were conducted decreased by 44% and became increasingly concentrated at the top 20 highest-volume clinical trial si…
AI Summary: A new analysis shows Phase I lung cancer trials are becoming concentrated at a relatively small number of leading U.S. centers, raising concerns about geographic inequity in access to early‑phase studies. The trend could speed drug development at elite sites while leaving patients in other regions with fewer experimental options and longer travel burdens.
- Conference highlights, care models and awareness (4)
- Consolidation at top U.S. Phase I centers (3)
- Early-phase trials and next-gen therapies (4)
- All Other Stories
Conference highlights, care models and awareness
Consolidation at top U.S. Phase I centers
Early-phase trials and next-gen therapies
All Other Stories
UK passes bill that will eventually ban cigarette purchases
abcnews - Parliament has passed a bill to make cigarettes inaccessible to future generations in the U.K. Children born after December 31, 2008, will never be able to buy cigarettes under the new Tobacco and Vapes Bill
AI Summary: The UK has passed legislation phasing out tobacco sales for younger generations, effectively banning cigarette purchases for people born after 2008. The law creates a rolling age‑based prohibition aimed at cutting smoking initiation and long‑term health harms, while stirring debate over enforcement, retail impact and the practicalities of turning childhood prevention into adult policy.
- Explainers and advocacy for the Tobacco and Vapes Bill (4)
- Health context: cancer burden and treatment equity (3)
- Parliament approves smoking ban for future generations (4)
- All Other Stories
Explainers and advocacy for the Tobacco and Vapes Bill
Health context: cancer burden and treatment equity
Parliament approves smoking ban for future generations
All Other Stories
340B drug discounts are drifting from patients to profit, and reform is now on the table
medicalxpress - The 340B Drug Pricing Program must be reformed to better patient health and disincentivize institutional profit-seeking behaviors, says the American College of Physicians (ACP). In a new policy, "Reforming 340B to Promote Program Integrity and Better Serv…
AI Summary: The 340B drug-discount program is under renewed scrutiny after analyses and advocacy groups argue discounts intended to help patients are instead boosting institutional margins. Hospitals, provider groups and the AHA are contesting HRSA proposals and court rulings, sparking policy debates and potential regulatory fixes to curb markups and steer savings back to vulnerable patients.
FDA updates mifepristone safety study status
Ella Jeffries / beckershospitalreview - The FDA updated its mifepristone guidance, detailing ongoing work on a safety study and the current status of the drug’s Risk Evaluation and Mitigation Strategy program. According to an April 8 news release, the agency said it is still collecting and eval…
AI Summary: The FDA updated the safety review status for mifepristone, yet the regulatory change hasn’t translated into widespread retail availability. Many community pharmacies are still hesitant to dispense the drug due to logistical, legal and reputational concerns, leaving access limited despite federal moves intended to broaden distribution — so yes, policy changed, but practice lagged.
'I'm not being listened to' - new health plan launched as women say they are still ignored
bbc - New plans to improve healthcare for women and girls have been set out, but will they change anything?
AI Summary: Health officials unveiled a new women's health plan, but many women say the rollout feels performative and that their concerns remain unheard. Patient advocates warn the initiative risks repeating past mistakes unless it embeds lived experience, transparent accountability and genuine co-design—otherwise it's policy theater with a glossy brochure.
AACR Announces 2026 Distinguished Service Award Recipients
oncodaily - The American Association for Cancer Research (AACR) has announced the recipients of its 2026 Distinguished Service Awards, recognizing individuals whose work has shaped the direction of cancer research, policy, and […]
AI Summary: The American Association for Cancer Research announced its 2026 Distinguished Service Award recipients, honoring leaders for exceptional contributions to cancer research, advocacy, and public engagement. The prizes celebrate scientific leadership across academia, clinical practice, and patient advocacy, reinforcing AACR’s priorities while handing the field a roster of role models to admire—and occasionally envy.
- Awards & grants: Distinguished Service, Trailblazers, scholar honors (4)
- Clinical highlights: Trials, company data, and therapeutic developments (5)
- On-site coverage: Live updates, press conferences, and recaps (4)
- Other: Attendee reflections and unrelated items (5)
- All Other Stories
Awards & grants: Distinguished Service, Trailblazers, scholar honors
Clinical highlights: Trials, company data, and therapeutic developments
On-site coverage: Live updates, press conferences, and recaps
Other: Attendee reflections and unrelated items
All Other Stories
Baylor Scott & White Health Plan to exit Medicaid, individual markets; cut 321 jobs
Jakob Emerson / beckershospitalreview - Baylor Scott & White Health Plan said April 14 it will exit the Texas Medicaid managed care market and discontinue its individual marketplace plans, affecting roughly 225,000 members and eliminating 321 jobs statewide, according to the Dallas Morning News…
AI Summary: Baylor Scott & White announced it will leave Medicaid individual markets, a move that will shed hundreds of jobs and reshape coverage options for affected enrollees. The decision highlights ongoing financial pressures in public‑program participation and raises practical concerns about access continuity for people reliant on those plans.
New Bill Seeks to Lower Out-of-Pocket Drug Costs
Marissa Plescia / medcitynews - Rep. Greg Murphy introduced a bill that would require out-of-pocket prescription drug spending to count toward patients’ deductibles and out-of-pocket maximums regardless of where the drugs are purchased.The post New Bill Seeks to Lower Out-of-Pocket Drug…
AI Summary: Lawmakers introduced legislation to reduce out‑of‑pocket drug costs by allowing patients' direct drug purchases to count toward their insurance deductibles. The proposal aims to ease financial strain for people buying costly medications out‑of‑pocket, but would require insurers and pharmacy systems to change longstanding accounting and benefits practices.
American Cancer Society Announces New Pediatric, Adolescent, and Young Adult Cancer Journal; Names Editor-in-Chief
cancer - The publication will provide a platform to share discoveries and advance knowledge across the field of pediatric and AYA oncology
AI Summary: The American Cancer Society launched a new open‑access journal dedicated to pediatric, adolescent and young adult oncology and named its inaugural editor‑in‑chief. The journal aims to centralize research, clinical guidance and policy discussions for younger patients, speeding dissemination of age‑specific evidence and, one hopes, improving outcomes for a frequently overlooked group.
- ACS launches open‑access journal centralizing pediatric and AYA oncology research (7)
- Adolescents and young adults: awareness, survivorship, transition and community (9)
- Global pediatric oncology gatherings spotlight collaboration, training and innovation (14)
- Other pediatric oncology news: research, partnerships, advocacy and care (24)
- All Other Stories
ACS launches open‑access journal centralizing pediatric and AYA oncology research
Adolescents and young adults: awareness, survivorship, transition and community
Global pediatric oncology gatherings spotlight collaboration, training and innovation
Other pediatric oncology news: research, partnerships, advocacy and care
All Other Stories
High-dose Wegovy debuts at $399 for self-paying patients
Paige Twenter / beckershospitalreview - Novo Nordisk’s recently approved high-dose Wegovy formulation has entered the U.S. market and is available for $399 per month for self-paying patients, the drugmaker said April 7. In March, the FDA approved Wegovy HD, a 7.2-mg injection of semaglutide, as…
AI Summary: Novo Nordisk has introduced a higher‑dose formulation of Wegovy (semaglutide) in the U.S., offering self‑pay patients access at a $399 monthly price. The rollout reflects growing demand for GLP‑1 therapies and fuels ongoing debates about affordability, access and how much of weight‑management care should depend on out‑of‑pocket spending.
- On scene: industry shifts, IPOs, stigma and miscellaneous reports (4)
- On site: Novo rolls out Wegovy HD, sparking access debates (7)
- Regulators press for more GLP-1 safety data and oversight (4)
- Reporting from clinics: GLP-1s vary in effect, risk muscle loss (9)
- All Other Stories
On scene: industry shifts, IPOs, stigma and miscellaneous reports
On site: Novo rolls out Wegovy HD, sparking access debates
Regulators press for more GLP-1 safety data and oversight
Reporting from clinics: GLP-1s vary in effect, risk muscle loss
All Other Stories
What are motor skills? Evidence‑based ways to support children's fine and gross motor development
medicalxpress - Motor skills are foundational for a lifetime of movement. For children, they play a vital role not only in facilitating physical activity levels but also for cognitive and socio-emotional development and school readiness.
AI Summary: New guidance summarizes evidence-based strategies to strengthen young children's fine and gross motor development, offering practical activities, screening cues and professional supports for parents and educators. The reporting emphasizes early intervention, play-based approaches and simple at-home exercises that can set the stage for healthier development without expensive gadgets or miracle fixes.
Orlando Health fleshes out Alabama footprint with another acquisition
fiercehealthcare - The $10 billion nonprofit plans to acquire RMC Health System from the City of Anniston, building on 2024's big-ticket purchase of five Alabama hospitals from Tenet Healthcare.
AI Summary: Orlando Health continued its regional growth by acquiring an Alabama health system, extending its clinical and operational footprint into the state. The move aims to integrate services, expand care access and consolidate regional networks as health systems seek scale to manage costs and enhance specialty offerings.
Cancer Risk Is Significantly Higher for Adults Who Never Married, Large Study Finds
oncodaily - Analysis of 4 million cases finds higher cancer rates across most types, especially for preventable cancers. Adults who have never been married face a significantly higher risk of developing cancer […]
AI Summary: A large observational analysis found that adults who never married have a significantly higher cancer risk compared with married peers, after adjusting for common confounders. Researchers highlight social, behavioral and access‑to‑care factors as possible contributors, suggesting that relationship status may serve as a marker for targeted prevention and support interventions.
- Lifestyle, sleep and fertility linked to cancer risk (3)
- Never-married adults face significantly higher cancer risk (3)
- Place, education and loneliness drive cancer disparities (3)
Lifestyle, sleep and fertility linked to cancer risk
Never-married adults face significantly higher cancer risk
Place, education and loneliness drive cancer disparities
UCLA Researchers Develop Low-Cost Blood Test to Detect Multiple Cancers And Other Diseases From a Single Sample
oncodaily - The new method analyzes genome-wide methylation of DNA circulating in the bloodstream to detect liver, lung, ovarian and stomach cancers, as well as several non-cancer conditions. UCLA scientists have developed […]
AI Summary: Researchers at UCLA introduced a low-cost blood test capable of detecting multiple cancers and other diseases from a single sample, promising broader screening reach and earlier detection. If validated at scale, the technology could lower barriers to multi-cancer screening, reshape diagnostic pathways, and offer cheaper, simpler surveillance—assuming the usual caveats about follow-up testing and false positives.
- Frontline: ctDNA and cfDNA - monitoring, screening, and reliability questions (4)
- On location: early-detection debates, AI risk stratification and screening value (4)
- On the ground: UCLA’s inexpensive blood test expands multi-disease detection (4)
- All Other Stories
Frontline: ctDNA and cfDNA - monitoring, screening, and reliability questions
On location: early-detection debates, AI risk stratification and screening value
On the ground: UCLA’s inexpensive blood test expands multi-disease detection
All Other Stories
Too young for the MMR shot, babies become 'sitting ducks' in measles outbreaks
medicalxpress - With baby Arthur too young for the measles vaccine and a sibling due in June, the Otwells grew nervous when the threat of the highly contagious virus started factoring into their grocery run.
AI Summary: Health reporting highlights that infants below the eligible age for the MMR vaccine remain highly vulnerable during measles outbreaks, effectively "sitting ducks" until immunization is possible. Public-health experts warn that gaps in community immunity and outbreak control measures disproportionately endanger these youngest children, underscoring the need for stronger herd-protection and targeted outbreak responses.
AbbVie sues HHS over 340B patient definition
Ella Jeffries / beckershospitalreview - AbbVie has filed a lawsuit challenging federal guidance on how “patient” is defined under the 340B program, according to an April 8 press release. The company said the current definition, based on guidance issued in 1996, allows covered entities to claim …
AI Summary: AbbVie has filed suit challenging HHS’s interpretation of the 340B program, arguing the agency’s “patient” definition and related guidance are outdated and legally flawed. The company seeks judicial clarity that could reshape who qualifies for discounted drugs and how hospitals and manufacturers navigate the program — yes, the pricing drama continues.